Evidence Hub

Prediction of melanoma metastasis using dermatoscopy deep features. An international multicenter cohort study

K. Lallas, P. Spyridonos, Harald Kittler, P. Tschandl, K. Liopyris, G. Argenziano, R. Bakos, Ralph P. Braun et al.

British Journal of Dermatology, 2024

712 participants · 7 citations

Abstract

Whether dermatoscopy deep features could serve as biomarker for the prediction of melanoma metastasis, remains an underexplored area in medical research. In this cohort of 712 patients from ten centers from 3 different continents, a support vector machine (SVM) classifier, analyzing deep features from dermatoscopic images, demonstrated similar prognostic performance for metastasis, in terms of AUC and true positive rate, to current benchmarks of melanoma staging, namely Breslow thickness and ulceration. Deep features derived from dermatoscopy could predict, at the time of diagnosis, early-stage melanomas with high metastatic potential, tailoring further treatment strategies.

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 712 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free